315 related articles for article (PubMed ID: 1090675)
1. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
Harada M; Pearson G; Redmon L; Winters E; Kasuga S
J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
[No Abstract] [Full Text] [Related]
4. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
Lamon EW; Gatti RA; Kiessling R; Fenyö EM
Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
Gorczynski RM; Knight RA
Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
[TBL] [Abstract][Full Text] [Related]
6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
8. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
Powell TJ; Spann R; Nguyenduc M; Lamon EW
J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
[TBL] [Abstract][Full Text] [Related]
9. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
10. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
Wood GW
Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
Pearson GR; Redmon LW; Bass LR
Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
[No Abstract] [Full Text] [Related]
12. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D
Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341
[TBL] [Abstract][Full Text] [Related]
13. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
[TBL] [Abstract][Full Text] [Related]
14. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
15. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
16. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
Tamerius JD; Hellström I
J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
[No Abstract] [Full Text] [Related]
17. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
18. Decrease of cytotoxic immune lymphoid cells following regression of virus-induced sarcomas in mice.
Levy JP; Lechlerc JC; Gomard E; Pavie J; Kourilsky F
Bibl Haematol; 1973; 39():689-97. PubMed ID: 4798253
[No Abstract] [Full Text] [Related]
19. Tumor-associated membrane antigens and the antitumor immune reactions.
Levy JP; Kourilsky FM
Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
[No Abstract] [Full Text] [Related]
20. Antibody-dependent, cell-mediated cytotoxicity with autochthonous lymphocytes and sera after infection with Moloney sarcoma virus.
Lamon EW; Hale P; Whitten HD
J Natl Cancer Inst; 1976 Feb; 56(2):349-55. PubMed ID: 1255765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
